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Summary This study tested the hypothesis that high dose systemic alfentanil administered before and during aMominal hysterec-
tomy would pre-empt post'operative pain to a greater extent than administration of either low dose alfentanil or no alfentanil peri-
operatively. Patients (ASA I or 2) were randomly assigned to group 1 (r = 15), no opioid; group 2 (n = 15), low dose alfentanil; or group 3
(n = l5). high dose alfentanil. Anaesthesia was induced in group I with midazolam and thiopentone and was maintained with isoflurane
andTO% N2O in 02, Anaesthesia was induced in group 2 with midazolam, thiopentone and i.v. alfentanil (30pg kg-l), and was main-
tained with isoflurane. 70VoN2O in 02, and bolus doses of i.v. alfentanil (10-20pg kg-l) every hour. Anaesthesia was induced in group 3
withmidazolamandi.v. alfentanl (l0opgkg-t),and wasmaintained wtlt70% N2Oin Oz,andanintusionof i.v. alfentanil(l-2pgkg-l
min-l). Blood samples were drawn at 30 and 120 min after surgery and assayed for plasma alfentanil. Morphine consumption and VAS
pain scores were consistently lowest in group 3 over the 48 h study period, A composite measure of pain and morphine consumption was
significantly lower in group 3 than group 2 up to 6 h after surgery and significantly lower than group I up to 12 h. No adverse effects were
observed. A 6-month follow-up did not reveal any significant differences among the three groups. It is concluded that intra-operative high
dose alfentanil anaesthetic pre-empts post-oporative pain after abdominal hysterectomy, but the effects are small and of short duration.
Surgical procedures carried out under general anaesthesia using standard (and even high) doses of opioids intraoperatively provide sub-
optimal protection from the injury banage brought about by incision and subsequent noxious surgical events.
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Introduction
Although the pre-operative administration of opioids has
a long history in anaesthesiology, only recently has this
well established practice been evaluated for potential anal-
gesic effects that extend beyond the duration of action of
the opioids. The rationale for predicting an extended anal-
gesic effect is derived from animal studies showing that
morphine prevents the establishment of injury-induced
central sensitization when given before but not after injury
,(Woolf and Wall 1986). The clinical implication of these
results is that the central sensitization that is presumed to
develop as a consequence of surgical trauma leads to an
amplification of peripheral input and increased post-
'-d6oraing author: Joel Katz, Department of Psychology, The
Toronto Hospital, General Division, 200 Elizabeth St., CW 2-306, To-
ronto. Ontario, MsG 2C4 Canada. Tel.: (l) 416-3403777; Fax; (l)
416-34M7 39; B-mail: j.katz@utoronto.caI Pnsent address: Ddpartement d'anesth€sie et r6animation, C.H.U.S.,
3001 I 2ibme avenue nord, Fleurimont, Qu6bec, JIH 5N4, Canada.
operative pain intensity,(Wall 1988; Codene et al. 1993;
Woolf and Chong 1993)
We recently demonstrated that pre-incisional treatment
with epidural fentanyl in patients undergoing thoracotomy
resulted in significantly lower pain and morphine con-
sumption compared with patients that received the same
treatment after incision (Katz et al. 1992a). These results
indicate that it is possible to pre-cmpt post-operative pain
with epidural opioids. The question of whether systemic
opioids pre-empt post-operative pain when given before
versus after incision or surgery also has been addressed
,(Richmond et al. 1993; Mansfield et al. 1994; Wilson et al.
1994; Collis et al. 1995; Fassoulaki et al. 1995). The results
of these studies are equivocal, with two showing reduced
pain and/or analgesic consumption following pre- but not
post-surgical administration of opioids .(Richmond et al.
1993; Collis et al. 1995) and others showing no. effect
,(Mansfield et al. 1994; Wilson et al. 1994; Fassoulaki et al.
1995), Methodological flaws and insufficient data presen-
tation make it difficult to interpret these results. However,
taken together, it appears that with doses routinely adminis-
tered during surgery under general anaesthesia, systemic
opioids may not produce a sufficiently dense blockade of
noxious peri-operative inputs to prevent central sensitiza-
tion in either the pre- or post-incisional group.
While the ability of systemic opioids to pre-empt post-
operative pain may be limited when administered as a
supplement to general anaesthesia, it is nonetheless possi-
ble that they create subtle pre-emptive effects which reduce
post-operative pain to a level that could make it difficult to
distinguish the pre-emptive benefits of a target troatment
(e.g. local anaesthetic infiltrations, nerve blocks, epidural
or spinally administered local anaesthetics or opioids)
given before versus after surgery .(Katz 1995). For exam-
ple, a number of recent studies evaluating the pre-emptive
analgesic effects of regional anaesthesia combined with
general anaesthesia have not found the expected reduction
in post-operative pain or analgesic requirements among
patients that received regional anacsthesia before versus
after surgery,(Dahl et al. 1992: Dierking et al. 1992; Pryle
et al. 1993). However, in these studies all patients also re-
ceived systemic opioids as pre-medication, at induction of
the general anaesthetic, or during surgery. The possibility
cannot be ruled out that the pre-operative adminisEation of
systemic opioids to all patients attenuated the development
of CNS sensitization in all patients and contributed to the
lack of a clinically significant outcome between pre- and
post-treated groups.(Katz et al. 1992b, 1993). In contrasq
studies that have shown a benefit of pre-incisional local
anaesthetic infiluation .(Ejlersen et al. 1992\ or epidural
analgesia/anaesthesia.(Katz et al. 1992a, 1994) over post-
incisional administration of the same agents by the same
route have not administered systemic opioids before or
during surgery. Taken together, these results suggest that
routine use of systemic opioids at induction of general an-
aesthesia and during surgery may provide subtle pre-
emptive analgesic effects that might make it difficult to
demonstrate a significant difference in post-operative
pain and analgesic requirements between pre- and post-
treated patients. The present study was therefore under-
taken in part to evaluate the pre-emptive effects of low
dose systemic alfentanil relative to a no-opioid control
group.
The present study was also designed to evaluate whether
the pre-emptive analgesic effect of systemic opioids is
dose-dependent. Collis et al. (1995) reported that 20 mg of
morphine administered before surgery did not appear to
offer an obvious advantage compared with their previous
study (Richmond et al. 1993) in which 10 mg of morphine
was administered, but the two doses were not compared in
a single study. Thus, we do not know whether increasing
the pre-emptive dose of an opioid will correspondingly
increase the clinical benefit when compared with a smaller
dose. In order to evaluate these aims, we compared the pre-
emptive analgesic effects of low and high dose alfentanil in
women undergoing abdominal hysterectomy with a control
group that did not receive alfentanil.
Material and methods
Approval to carry out the study was obtained from the Toronto Hospi-
tal Committee for Research on Human Subjccts. All patients gave their
written informed consent to panicipate before entering the study.
Patient selection
Patients (ASA physical status l-2) scheduled for total abdominal
hysterectomy with or without bilaterol salpingo-oopherectomy were in-
cluded in the study. Exclusion criteria were ASA physical status > 2, age
less than I 8 or greater than 80 years, w€ight >75 kg, non-English speak-
ing, and history ofmajor psychopathology.
Randomization and blinding procedures
Before the start of the study, a computer-generated randomization
schedule was used to speci$ the group (l =no opioid, 2=low dose
alfentanil, or 3 = high dose alfentanil) io which each prospective patient
would be assigned upon entry into the trial (Dallal 1988). An envelope
containing the group assignment was prcpared, sealed and numbered for
each prospective patient. On the morning of the surgery, the anaesthesi-
ologist in charge of the case opened the patient's envelope, rcad its con-
tents, and prepared the syringcs of alfentanil for subsequent administra-
tion.
All patiena and personnel involved in patient managemcnt and data
collection were unaware of the group to which the patient had been as-
signcd. The only individual who was not blinded was the anaesthesiolo-
gist in charge of the case who was not involved in the patient's post-
operative care or data collection.
P re- operative as se s sment
The day before surgery, patients were interviewed by a member of the
Acute Pain Rescarch Unit. Patients were familiarized with the visual
analogue pain scale (VAS) and were introduced to the petient-conuolled
analgcsia (PCA) pump and carefully instructed in its use.
General anaesthesia
All patients received diazepam p.o. (5-10 mg) 2 h prior to surgery 8s
prc-medication. Patients were assigned at random to one of three groups.
As detailed below, gmup I did not rcceive opioids, group 2 received low
dose alfentanil and group 3 received high dose alfentanil. After induction
of anaesthesi4 all patients had a radial arterial catheter inserted for posr
operative blood sampling to rneiLsure plasmo alfentanil levels and arterial
blood gases.
For patients in gmup l, anaesthesia was induced with i.v. midazolam
(0,05 mg kg-l; and thiopentone (3-5 mg kg-l). Muscle rrlaxation and
tracheal intubation were facilitated with vecuronium (0.1-O.15 mg kg-l).
Anaesthesia was mqintained with isoflurane and 7U% N2O in O2. Opioids
w€re not administered at induction or intra-operatively.
For patients in group 2, anaesthesia was induced with i.v. alfentanil
(30pg kg-t), i.v. midazolam (0.05 mg kg-l;, and thiopentone (3-5 mg
kg-'). Muscle relaxation and tracheal intubation werc facilitated with
vecuronium (0.t-O.15 mg kg-l). Anaesthesia was maintained with 70%
N2O in 02, isoflurane and bolus dose.s of i.v. alfentanil (10-20pg kg-I)
every hour. For gmups I and 2, isoflurane was titrated to maintain sys-
tolic blood pressure within 20% of baseline systolic blood pressure de-
rived from pre-operative ward measurements.
For pafienls in group 3, anaesthesia was induced with i.v. midazolam
(0.05 mg kg-l; and i.v. alfentanil (l00pg kg-l). Muscle relaxation and
tracheal intubation were facilitated with vecuronium (0.t-{.15 mg kg-l).
Anaesthesia was maintained with 7O% NrO in Or and a continuous infu-
sion of i.v. alfentanil (l-2Fg kg-l'61n-1r. 'fhe-alfentanil dose was ad-
justed to maintain hemodynamic variables within 20% of pre-operotive
ward values by administering a bolus dose of i.v. alfentanil (10-20pg
kf') and increasing the alfentanil infusion by increments of 0.254.5pg
kg-' min-'. The alfentanil infusion w&s discontinued 30min before the
anticipated end of surgery.
Patients received propranolol (0.5-l.0mg) if tachycardia or hyper-
tension was not controlled by the above regimens. At the conclusion of
the surgery. neuromuscular blockade was reversed with neostigmine
(0.05 mg kg-l) and gtycopyrrolate (0.01 mg kg-l;. The trachea was ex-
tubated after emergence and upon rcsumption of spontaneous breathing.
Patients received supplemental 02 by mask and wcre transported to the
postanaesthetic care unit (PACU).
P eri-operative monitoring
All patients were continuousty monitored throughout the procedure
with a non-inva.sive blood pr€ssurc cuff, electrocardiogram, pulse oxime-
ter, temperature pmbe, nerve stimulator and end-tidal carbon dioxide and
anaesthetic agent analyzer. For groups I and 2, mean end-tidal isoflurane
concentration was calculated for each 5 min block beginning after induc-
tion of anaesthesia until the end of surgery.
P o s t - o p e rat iv e mf,tne g eme nt
Patients were assessed immediately upon arrival in the PACU. A
PCA pump system (Abbott Life Care Infuser, Chicago, IL) was con-
nected to the indwelling i.v. cannula. Every l0 min, patients were asked
whether they were in need of pain relief. An afiirmative response was
followed by a 2 mg intravenous bolus of morphine administered by a
nurse observer who was unaware of thc group to which the patients had
been assigned. This procedure was repeated until the patients were alert
enough to begin using the PCA pump. The PCA pump was set to deliver
a 1.5-2.0 mg intravenous bolus dose of morphine with a lock-out time of
5-7 min, a maximum dose of 30 mg in any 4 h period, and no continuous
background infusion. This regimen was overseen by the Acute Pain
Service (APS) and was continued on the ward for 48 h during which no
other analgesics were administered. APS personnel were unaware of the
group to which patients had been assigned. Morphine (mg) usage was
calculated from hard copy records (Abbott TRW Printer Model TP 40).
P ost-ope rat iv e pain meas urement
A lO-cm VAS (with endpoints labelled 'no pain' and 'worst possible
pain') wa.s used to assess pain intensity at r€st (VAS-R) 2, 4, 6, 12,24
and 48 h after the completion of surgery, Pain after movemeDt (VAS-M)
was assessed at 24 and 48 h by asking patients to sit up from a lying
position and perform two maximal inspirations using an incentive spi-
rometer b€forc rating their pain.
Pain was also assessed at 24 and 48 h using the McGill Pain Ques-
tionnaire (MPQ),(Melzack 1975). The MPQ consists of 20 sets of words,
each containing from two to six adjectives that describe the sensory,
affective, or evaluative properties of pain, The list of pain descriptors was
read to the patient who chose the words that b€st describ€d her pain at the
moment. The MPQ yields two global scores, the pain rating index (PRI)
and the present pain intensity (PPl) . The total pain rating index (PRI-T)
is the sum of the rank values of the descriptors chosen from the 20 sets.
The PPI is rated on a scale of 0--5 as follows: 0 = no pain, I = mild, 2 =
discomforting, 3 = distressing, 4 = horrible, 5 = excruciating.
P lasma aIft ntanil concentrations and p harmacokinetic s
Blood samples (l0cc) were drawn in all patients from a radial artery
at 30 min and 120 min after arrival in the PACU. Samples were collected
in heparinized glass vials, centrifuged immediately, and the separated
pla.sma stored at 
-27"C until analysis at the end of the study. Assays were
performed by a blinded technician on samples obtained from patients in
groups 2 and 3 only. Concentrations of alfentanil were measured in du-
plicate using a specific radioimmunoassay kit (Janssen Biotech NV Re-
search Products). The sensitivity of the assay is 0. I ng ml-l and the intra-
and inter-a^ssay coefficients of variation covering the therapeutic range of
concentrations are <10%(Michiels et al. 1983).
Pharmacokinetic porameters were calculated using standard proce-
dures dGibaldi and Perrier 1982). Plasma alfentanil holf-life was calcu-
lated for each patient using the formula 4n=O.6931k, where k is the
elimination rate constant. The elimination rate constant was determined
by the formula k = In Cr - ln C2lQ2-tr), where C1 and C2are plasma
alfenranil concentrations taken 30 afld 120 min after surgery, rcspec-
tively. Plasma alfentanil concentrations (C1) were exrapolated to 4, 6,
and 12 h after surgery using the following formula for dcscribing first-
order elimination: C; 
= f,r6-k(! - t2).
P o s t - o p e rat iv e fo llow - up
Six months after surgery, patients were contacted by telephone by a
research assistant who was untware of the group to which the patient had
been assigned at the time of surgery. A brief, srandardized questionnaire
was administered to each patient assessing the presence and inrcnsity of
pain at the site of the sqr at rest and after movement. All patients rated
the pain on a 0-10-point ve6al rating scale (VRS) with endpoints speci-
fied as 'no pain' and 'worst possible pain'. All patients also rated tlreir
pain using the PPI scale of the MPQ.(Melzack 1975).
The interviewer assessed whcther certain movements wer€ associated
with pain onset or exacerbation. Specifically, patients were askcd to run
their finger along the scar, to take a deep breath and cough, and to sit up
from a lying position. Prtients rated the ensuing pain after each of these
manoeuvrcs using a 0-10-point VRS.
Statistical analysis
Domographic, clinical, and intn-operative treatment variables were
analyzed by chi-squared test (frequency data) or one-way, betwe€n-
groups ANOVA (paranletdc data).
VAS-R, VAS-M, MPQ scores, and an integrated analgesic assessment
score, consisting of a composite measure of VAS-R and PCA morpbine
consumption (Silverman et al. 1993) wcre analyzed by non-paranretric
IGuskal Wallis ANOVA of ranks. Significant effects were followed up
with non-parametric Student-Newman-Keuls multiple comparison pro-
cedure (Glantz I 992) to determine the pattem of significance among the
three groups. The integrated analgesic a.ssessmcnt score.(Silverman et al.
1993) is calculated by separately rank ordering pain scores and morphine
consumption, obraining a difference score for each individual rank by
subtracting it from its mean, expressing the difference scorr as a p€rcent-
age of the mean rank, and summing the % differences for pain and mor-
phine. This procedure yields a composite pain and morphinc score that
r€presents the % difference from the mean overall rank (i.e. 0%) and
ranges between 
-200% (most comfortable) and +2OO% (least comfort-
able).
One-way, between-groups ANOVA with Bonferroni's conrection (a/
number of tests) was used to analyze morphine consumed within inter-
vals bounded by the times when pain assessments were carried out. Sig-
nificant effects were followed up with Tukey's posFhoc tests to deter-
mine the pattem of differences between pairs of means. Cumulative mor-
phine consumption at 48 h wa^s analyzed by one-way ANOVA. Plasma
alfentanil concentrations were analyzed by two-woy r€peated nnasur€s
ANOVA using group (2, 3) as the independent samples factor and tirne
(30min and l2Omin) as the rspeated me&sures factor. Terminal alfen-
tanil halHife was analyzed by two+ailed unpair€d r-test.
long+erm follow up data were analyzed by chi-squared test for fre-
quency data and Kruskal-Wallis ANOVA of ranks. All data are presented
as mean t SD unless otherwise specified. P < 0.05 is considercd statisti-
cally significant.
Results
Patient withdrawals
Fifty-one patients were recruited in order to achieve a
sample size of 15 patients per group. In total, six patients
were withdrawn from the study. One patient received addi-
tional analgesics from personnel not involved in the study
5 h after surgery, three developed complications necessitat-
TABLE I
MEAN (SD) CLINICAL, DEMOCRAPHIC, AND INTRAOPERATIVE
TREATMENT VARIABLES FOR THE THREE GROUPS
Group I Group 2 Group 3
I
f,u t
@
246122448
Hours after surgery
Fig. |. Mean visual analogue pain scores at rest (VAS-R) for the thrEe
groups. *P=0.003 forgroup I versus 3,**P=O.02 forgroup I versus 2
and P = 0.01 for group I versus 3.
groups (both P < 0.05) between 0 h and 2h after surgery
(Fig. 2). At the conclusion of the study, 48 h after surgery,
cumulative morphine (mg) was 108.1 t 52.5,96.7 +41.4,
and 9l.l + 35.3 for groups l, 2 and 3, respectively (Table
ry).
Use of the composite measure of VAS-R and PCA mor-
phine consumption maximized the differences in analgesic
effect among the three $oups (Fig. 3). The integrated anal-
gesic assessment scores for group 3 were significantly
lower than the two other groups at 2 h, 4 h, and 6 h after
surgery (all P < 0.05) and lower than group I at l2h (P -
0.0s).
McGill Pain Questionnaire PRI-T scores did not differ
significantly among the three groups (Table V). Table VI
shows the MPQ descriptors chosen by more than 337o of
patients in the three groups 24h and 48h after surgery,
Ovcrall, significantly fewer patients in group 3 endorsed
descriptors indicative of pain when compared with the
other two groups (Xz(t) = 4.4, P = A,M).
Plasnn levels of alfentanil
Plasma levels of alfentanil were available at 30 min and
l2Omin after surgery for 10 patients in group 2 and 1l
patients in group 3 (Table VII). The ANOVA showed a
significant main effect of group (F(1,19)=25.3, P<
0.0001), time (F(1,19)=97.6, P<0.0001) and a signifi-
cant group by time interaction (F(1,19) = 37.8, P <
0.0001), Examination of the interaction showed that the
TABLE ITI
MEAN (SD) VAS PAIN SCORES FOR THE THREE CROUPS AFTER
STANDARD MOBILIZATION (VAS-M)
Time after surgery (h) Group I Group 2 Group 3
ASAstatusa(l:2)
Age (years)
Weight (kg)
Surgery duration (min)
Blood loss (ml)
Total alfentanil (mg)
Propranolol (mg)
Isofluraneo (7o)
l5:0
41.4 (7.8)
62.7 (7.8)
86.s (3s.2)
213 (158.6)
0.0
0.53 (0. l4)
t.2 (0.27)
l3:2
46.t (5.9)
66.3 (l r.6)
84.0 (30.4)
369 (42t.6)
3.31(o.ss)
0.0
0.88 (0.16)
l2:.7
45.9 (7.6)
67.9 (9.2)
90.r (26.s)
439 (484.8)
t'l.48 (s.92)
0.0
0.0
aNumber of patients classified as status I and 2.
bMean end-tidat isoflurane concentration in 5 min blocks.
ing further surgery, and two were withdrawn due to intra-
operative protocol violations.
Demo graphic, clinical and intra-ope rative treatment
variables
The three groups did not differ significantly on
demographic variables (Table I) or in frequency of diag-
nosis, incision type or surgical procedure (Table II). Group
3 received significantly more alfentanil than group 2
(F(1,28)=85.1, P<0.0001). Mean isoflurane require-
ments were significantly greater in group 1 than group 2
(F(1, 28) = 14.0, P < 0.001). Nine patients in group I re-
ceived propranolol (1C2(2) =22.5, P = 0.0001).
Pain and morphine consumption
VAS-R pain scores were consistently lowest in the high
dose group across the entire 48 h study period (Fig. 1).
VAS-R was significantly lower for group 3 than group I at
2 h (P = 0.003) and 4 h (P = 0.01) and significantly lower
for group 2 than group I at 4 h (P = 0.02) after surgery.
VAS-M pain scores did not differ significantly among the
three groups (Table III). Morphine consumption was sig-
nificantly lower in group 3 than either of the two other
TABLE II
FREQUENCY OF DIACNOSIS, PROCEDURE AND TYPE OF
INCISION FOR THE THREE GROUPS
Group I Group 2 Croup 3
Diagnosis
Fibroids
Endometrial carcinoma
Endometriosis
PMSq/abdomihal pain
Pnrcedure
Total abdominal hysterectomy
Total abdominal hysterectomY
+ bilateral salpingo-oophorectomy
Type ol incision
Horizontal
Midline
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Fig. 2. Mean PCA morphine consumption for the three groups within
time intervals bounded by VAS-R pain assessments. *P < 0.05 for group
I versus 2 and group I versus 3,
alfentanil plasma level in group 3 was significantly greater
than that of group 2 at 30 min (F(1,20) = 32.2, P < 0.0001)
and l20min (F(1,19)=20.1, P<0.0001), In addition,
plasma levels decreased significantly from 30 min to
120 min in group 2 (F(1,9) = 45.7, P < 0.0001) and group
3 (r(1,10) =76.2, P < 0.0001).
The mean terminal half'life of alfentanil was estimated
to be 2.8 t 1.3 h and 1.8 + 0.9 h for the high and low dose
alfentanil groups, respectively ((19)=2.1, P=0.05). We
extrapolated plasma levels out to 12 h after surgery based
on the terminal half-life. Table VII shows estimated mean
plasma concentrations in the high dose group 4 h, 6 h, and
12h after surgery.
Adverse effects
No adverse effects were observed.
Six monthfollow-up
Of the 45 patients who completed the study, 38 were
contacted by telephone and interviewed 6 months after
surgery. Three patients in group l, two in group 2, and two
in group 3 could not be reached. One patient in group 2
who was contacted was subsequently excluded because she
had undergone three additional abdominal surgeries in the
TABLE IV
MEAN (SD) CUMULATIVE PCA MORPHINE (MG) CONSUMPTION
FOR THE THREE CROUPS
Time after surgery (h) Group I Group 2 Group 3
12h 24h 48h
Time aftersurgery
Fig. 3. Box-and-whisker plots of rhe integrated analgesic &ssessment
scoring method consisting of a composite measurc of VAS pain scorcs at
rest and PCA morphine consumption. The median is identified by the
centre horimntal line partitioning the box. The first and third quartiles
are at the ends of the box (i,c. 50% of the observations fall within the
box). The extrcme values identify 1.5 x interquartile range. Groups l, 2,
and 3 are symbolized by black, cross-hatched, and white boxes, respec-
tively. **p.g.O5 forgroup I versus 3 and group 2 versus 3; *P<0.05
for group I versus 3,
intervening 6 months. Table VIII shows the frequency and
intensity of pain experienced by the three groups. Sponta-
neous pain at rest was reported by three patients (one in
group I and two in group 3) all of whom localized the pain
to the scar. The number of patients reporting evoked pain
(having patients run a finger along the scar, sit up, and
cough) did not differ among the three groups.
Discussion
The results of the present study support the hypothesis
TABLE V
MEAN (SD) MPQ SCORES FOR THE THREE GROUPS 24 AND 48 H
AFTER SURCERY SHOWING THE TOTAL PRI, PPI, AND TOTAL
NUMBER OF WORDS CHOSEN (TOTAL WORDS).
Group I Group 2 Group 3
6
t2
24
48
r5.3 (6.r)
23.2 (8.7)
28.8 ( l r.2)
42.2(t6.r)
68.2 (28.0)
r 08. l (s2.s)
17.7 (7 .9)
27.3 (t0.7)
32.7 (t3.tt
43.9 (r6.6)
66.5 (24.2)
96;t (4t.4)
r0. l (3.9)
r8.0 (7.0)
23.4 (9.6)
33.5 ( r r.8)
56.7 (20. l)
9 r.l (3s.3)
24h
Total PRI
PPI
Total words
48h
Total PRI
PPI
Total words
22.4 (r4.t)
r.9 (0.9)
ti.2 (t0.2)
12.5 (10.7)
r ,4 ( r.0)
'7.6 (6.4)
22.7 (t4.5')
|.7 (0.8)
tz.t (6.4\
14.3 (r0.2)
1.5 (0.8)
e. r (6.8)
t4.5 (12.6)
r.6(r.r)
8.7 (8.9)
ls.5 (r4.r)
1.4 (0.9)
8.6 (8.3)
TABLEVI
MPQ DESCRIPTORS
PATIENTS IN THE
SURGERY
CHOSEN 8Y ONE-THIRD OR MORE OF
THREE CROUPS 24 AND 48H AFTER
TABLEVIII
SIX-MONTH FOLI,oW.UP DATA SHOWING FREQUENCY AND
INTENSITY OF PAIN FOR THETHREEGROUPS
6
38
38
:
62
62
38
36
50
*-
Miscell. 
= 
miscellaneous.
that administration of i.v. alfentanil bcfore and during sur-
gcry pr€-empts post-operative pain afrcr abdominal hyster-
ectomy but the effects are small and of relatively short du-
ration. Pain and morphine consumption were consistently
lowest for group 3 across the 48 h assessment period. The
composite measure of pain and morphine consumption was
significantly lower in group 3 than group I up to l2h after
surgery at a time when the estimated mean plasma concen-
tration of alfentanil in the high dose group was below the
minimum effcctive analgesic plasma concentration for
awake patients in the early post-operative period (Camu et
al.1982; Persson et al. 1988). In addition, results from the
MPQ, 24 and 48 h after surgery, showed that fewer patients
in group 3 than in the two other groups endorsed descrip-
tors indicative of pain. However, 6 months after surgery the
three groups could not be distinguished on the basis ofpain
incidence.
The analgesic effects of alfentanil in awake subjects are
dose-related (Hill et al. 1986). The mean minimum effec-
TABLE VII
MEAN (SD) OBSERVED (30 AND I2O MIN) AND EXTRAPOLATED
(4, 6 AND 12 H) PLASMA ALFEMANIL CONCENTRATIONS (NG
Mrl) FOR GROUPS 2 AND 3
Time rftcr surgery Group 2 Group 3
Group 2 Group 3
(n 
= 12) (a = 13)
Months since surgery
Pain at tine of interview (n)
VRS at time of interview
Pain in past week (z)
VRS for past week
PPI forpast wcck
Pain when touches scar (a)
Pain whcn sits up (n)
Pain when coughs (z)
6.3 (0.3)
I
7.5
6
3.4(2.4)
r.3 (0.5)
I
I
0
6.6 (0.9) 6.3 (0.5)
o2
0 r.0 (1.4)
)1
6.0 (r.4) 2.4 (1.5)
3.O(t.4) r.r (0.4)
ll.
o4
l3
All data represent mean (SD) values unless otherwise specified.
tive analgesic plasma concentration in the eady post-
operative period has been reported to range from approxi-
mately 35 ng ml-r to 56 ng ml-r.(Persson et al. 1988; Camu
and Debucquoy l99l). In order to evaluate whether the
observed differences in analgesia might have been due to
the presence of therapeutic alfentanil concenEations, we
extapolated alfentanil concentrations to 12 h after surgery.
The estimated concentration of 21.8 ng ml-t for the high
dose gtoup 12 h after surgery was lower than the reported
minimum effective analgesic plasma concentration. In
addition, given the significant difference in half-life be-
tween groups 2 and 3, it is likely that alfentanil undergoes
saturation pharmacokinetics with high doses. The differ-
ence in halfJife was not explained by patient characteris-
tics such as age, weight, surgery duration, or procedure,
supporting the suggestion that the higher dose led to non-
linear pharmacokinetics. These considerations suggest that
the estimation of plasma alfentanil concentrations by
a monoexponential function (i.e. first-order elimination)
probably resulted in an overestimate of the actual alfentanil
concentration at lzh. Blood sampting at a later time (i.e.
when cnzyme systems were not saturated) may have re-
sulted in a shorter half-life due to changes in clearancc rate
relative to alfentanil concentrations. Thus, the significantly
lower composite measure of pain and morphine consump-
tion in group 3 compared with group 2 12 houn after sur-
gery is likely due to a true pre-emptive analgesic effect
rather than a lingering pharmacological effect of alfentanil.
The evidencc for a clear-cut, dose-dependent pre-
emptive analgesic effect is less convincing. A pre-emptive
effect of low dose alfentanil was demonstrated at 4 h since
VAS-R pain scores were lower in group 2 compared with
group I at a time when cumulative morphine consumption
did not differ significantly between the two groups and
when the estimated mean plasma alfentanil concentration
in group 2 (9.0 ng ml-l) was sub-therapeutic. As discussed
above, the pre-emptive effect of high dose alfentanil was
observed l?h after surgery when the integra&ed analgesic
assessment scores in group 3 were significantly lower than
group l. More importantly, at 2h,4h, and 6h after sur-
Group I
(n 
= 
12)Group 3
(%)
Group I
(%)
Time MPQ(h) class MPQdcscriptor Group 2(%)
Sensory Throbbing
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Stabbing
Cutting
Cramping
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Aching
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Exhausting
Sickening
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aPlasma conccntrations at 4 h, 6 h, and 12 h arc estimates based on the
terminot half- life calculated from the 30min and l2Omin values. See
tcxt for dctails.
gery, the integrated analgesic assessment scores in group 3
were significantly lower than in group 2, suggesting a
dose-dependent effect. However, we cannot be certain that
these latter differences reflect a pre-emptive analgesic ef-
fect since actual (2 h) and estimated (4 h and 6 h) plasma
levels of alfentanil in group 3 appeared to be above the
effective analgesic concentration reported ,(Camu et al.
1982; Persson et al. 1988).
The results of the present study confirm and extend
the findings by Kiss and Killian .(1992\, Richmond et al.
,(1993), and Collis et al. .(1995). The mechanism(s) by
which systemic alfentanil pre-empted pain are not known
but there are at least two possibilities. One is that noxious
peri-operative inputs induced a state of central neural sen-
sitization in group I which amplified inputs from the
wound and led to enhanced post-op€rative pain intensity
and increased requirements for morphine. Systemic ad-
ministration of alfentanil in groups 2 and 3 before and
during surgery attenuated the noxious central neural effects
of surgery relative to group I so that pain and morphine
requirements were reduced in the early post-op€rative pe-
riod.
Another explanation for the observed pre-emptive anal-
gesic effect is based on evidence that systemic administra-
tion of p opioid agonists reduces injury-induced inflamma-
tion and plasma extravasation by their peripheral and cen-
tral actions.(Joris et al. 1990; Barber and Gottschlich 1992;
Gavalas et al. 1994, Stein 1995). According to this possi-
bility, administration of alfentanil may have exerted a pre-
emptive effect by reducing the extent of peripheral in-
flammation and, hence, pain in groups 2 and 3 relative to
group 1. Thus, it may be that systemic opioids pre-empt
post-operative pain by more than one mechanism, In addi-
tion to attenuating the effects of the afferent banage asso-
ciated with surgery, it is possible that opioids act by reduc-
ing the extent of peripheral inflammation following sur-
gery.
When this possibility is considered in conjunction with
the finding that inflammation increases the anti-nociceptive
potency of ,r-opioid agonists such as morphine and fen-
tanyl (Stanfa et al. 1992; Antonijevic et al. 1995; Ossipov
et al. 1995), it raises questions about how to interpret the
lack of a difference in cumulative PCA morphine con-
sumption among the three groups. If development of in-
flammation is attenuated by systemic opioids and if the
potency of morphine increases in the presence of inflam-
mation, then compared to group 3, group I would have
developed a greater degree of inflammation and pain, but
would not have required more morphine to reduce the pain
to an intensity comparable to group 3 (due to increased
morphine potency in the presence of inflammation). It is
not inconceivable, therefore, that the magnitude of the pre-
emptive analgesic effect in group 3 was underestimated,
since groups I and 3 would be expected to have self-
administered similar amounts of morphine even though
inflammation-induced pain might have been more intense
in group l. In general, using a fixed post-operative analge-
sic regimen and looking for inter-group differences in pain
intensity(see e.g. Tverskoy et al. 1990, 1994) would obvi-
ate this potential problem and provide a more direct test of
the predictions of pre-emptive analgesia; namely, reduced
pain when resting and moving about.
The pre-emptive analgesic effect observed in the present
study appears to conflict with the results of three studies
which failed to find differences in post-operative pain in-
tensity or morphine consumptio4 in favour of patients
treated with low dose systemic opioids before versus after
incision,(Mansfield et al. 1994; Wilson et al. 1994 Fassou-
laki et al. 1995). However, differences in the design, opioid
doses, and conduct of the studies may explain the inconsis-
tent outcomes,
In the study by Wilson et al. .(1994) patients received
either alfentanil 40 pg kg-l t0 min before and saline I min
after skin incision, or saline l0 min before and alfentanil
4O l.tgkgt 1 min after skin incision. The absence of differ-
ences between the groups in post-operative morphine con-
sumption and pain at 24h may ,be confirmation, in the
clinical setting, of the findings by Wall and Woolf .(1984)
that high intensity noxious stimul4tion of C-fibre afferents
located in skin is considerably less effective in inducing
prolonged central facilitation than stimulation of afferents
located in deep tissue. Since alfentanil was administered
only I min after skin incision in the post-incisional group,
it is unlikely that damage had been done to deeper tissues
which contain the C-fibre afferents responsible for induc-
ing long-lasting central neural hypgrexcitability.
The administration of alfentanil after only I min of no-
ciceptive input raises the question of the time course of
central sensitization and whether hyperexcitability can be
prevented by an early post-incisional treatment. Electro-
physiological studies in rats have $hown that second-phase
formalin responses of dorsal horn nociceptive neurons are
inhibited to the same degree when a p-opioid agonist is
administered intrathecally before or shortly (i.e. 9 min)
after formalin injury.(Chapman et al. 1994). However, pre-
injury administration is significantly more effective at in-
hibiting second-phase responses than late (i.e, 30 min)
post-injury administration. One implication of these find-
ings for clinical studies is that administration of pr-opioid
agonists may be equally effective before and after incision
until central sensitization has developed but once estab-
lished, higher doses may be required post-surgery to pro-
vide the same degree of post-operative pain relief. In the
study by Wilson et al..(1994), it is likely that central sensi-
tization had not fully developed by I min after incision,
suggesting that the pre-emptive analgesic potential of alfen-
tanil was missed by virtue of too early an intervention post-
incision.
In addition, in the study by Wilson et al. (1994), all pa-
tients received morphine 0. I mg kg-l I min after incision.
This means that patients in the two groups were not treated
identically with respect to the timing of opioid administra-
tion relative to incision. This criticism applies to the study
by Mansfield et al. (1994) as well. Finally, although cumu-
lative PCA morphine consumption did not differ between
the groups, pain ratings were not obtained until Z h after
surgery. The presence of inter-group differences in pain
intensity within the frst 24 h would have been missed.
Post-operative PCA morphine consumption is not a substi-
tute measure of pain. Factors other than pain govern the
amount of morphine patients self-administer. These include
extent of adverse effects (nausea, pruritis, drowsiness) as
well as psychological variables. In light of our past,(Katz et
al. 1992a; Kavanagh et al. 1994a) and present results, as
well as those of others (Silverman et al. 1993), it is clear
that both pain and analgesic consumption must be meas-
ured in order to obtain an accurate appraisal of patient
comfort.
Mansfield et al.,(1994) administered l5pg kg-r alfen-
tanil before or l0 min after incision. In addition, both
groups received 0.2mg kg-l morphine lOmin after inci
sion. Differences in post-operative pain intensity or mor-
phine consumption between the groups were not detected
at2h,6h or 24 h after surgery. Given the relatively small
pre-emptive effect observed in group 2 patients in the pres-
ent study using twice the dose of alfentanil (30pg kg-t),
the lack of a pre-emptive effect in the study by Mansfield
et al..(1994) is, as the authors themselves point out, likely
due to an insufficient dose of alfentanil in combination
with the administration of morphine to all patients after
incision.
In the study by Fassoulaki et al..(1995), fentanyl OA pg
kg-r) or sufentanil (lpgkg-t) was administered before or
after incision or surgery. Post-operatively, pain was meas-
ured every 30 min until the first request for analgesia. Pa-
tients were then placed on a fixed analgesic regimen for the
duration of the study. The pre-incisional groups did not
show the anticipated pre-emptive analgesic effect. How-
ever, as with the study by Wilson et al..(1994), the presence
of inter-group differences in pain intensity would have
been missed since pain was not assessed between the time
patients first requested analgesics and the end of the study.
There were no significant inter-group differences in time
from skin closure to first analgesic request, but this
measure is not meaningful in studies of pre-emptive anal-
gesia which evaluate the timing of opioid administration
relative to incision. A more appropriate measure would
be time from administration of the opioid to the first re-
quest.
The most obvious difference between the present study
and those carried out by Wilson et al.,(1994), Mansfield et
al..(199a) and Fassoulaki et al. ,(1995) is our omission of
post-incisional alfentanil treatments. This may be an impor-
tant factor in explaining the inconsistent results since we do
not know the time course of central sensitization in the
post-operative setting or whether it can be prevented or
significantly attenua0ed by an early (e.g. I min or 10 min)
post-injury treatment. Elsewhere, we have argued that use
of the term pre-emptive analgesia to refer exclusively to
evidence that pre-operative treatment is more effective than
post-operative treatrnent (as opposed to no treatrnent or a
placebo treatment) is too restrictive and narrow {Katz
1995). It has been argued that evidence of pre-emptivc an-
algesia requires conhol of the same intervention made after
surgery (McQuay 1992), but in doing so, it may not be
possible, or even desirable, to ensure that the groups are
Eeated similarly with respect to other anaesthetic agents
.(e.g. see Katz et al. 1994).
Demonstrating that pre-treatrnent with analgesic agents,
but not a placebo, lessens pain and decreases post-operative
analgesic requirements at a time when the agents are no
longer clinically active, suggests that the central component
of post-operative pain can be prevented or pre-empted. In
0re absence of a post-incisional or post-operative control
condition, it may not be possible to determinc whether
factors associated with the intra-operative or post-operative
period (or both) are necessary for the enhanced post-
operative pain experience. Nevertheless, in the absence of a
post-treatrnent condition, the finding that pain or analgesic
consumption is reduced relative to an untreated control
condition is evidence of a pre-emptive analgesic effect
providing the agent administered pre-emptively is no
longer clinically active.
In spite of the many differences in design and method-
ology, the results of pre-emptive studies using systemic
opioids suggest that routine pre- and intra-operative doscs
of systemic opioids do not provide sufficient blockade of
the nociceptive banage during surgery to prevent the de-
velopment of central sensitization. This is consistent with
recent animal experiments (Abram and Olson 1994). How-
ever, low dose opioids given before or during surgery do
create subtle pre-emptive effects which reduce post-
operative pain to a level that would make it difficult to dis-
tinguish a bencficial effect of a target treatmcnt given be-
fore versus after surgery.(Katz 1995; Yashpal et al. 1996).
Our previous work in this area suggests that the epidural
route(Katz et al. 1992a, 1994) may be more effective than
other routes (Kavanagh et al. 1994b), perhaps because it
provides more direct access to and blockade of spinal neu-
rons responsible for the processing and transmission of
nociceptive information.
The small pre-emptive analgesic effects observed in the
present study, coupled with the high dose of alfentanil re-
quired to demonstrate these effects, suggest that the find-
ings are more of mechanistic than practical significance.
However, the lack of a clinically significant pre-emptive
effect is itself notable, since this implies that surgical pro-
cedures canied out under general anaesthesia using stan-
dard (and even high) doses of opioids intraoperatively
provide sub-optimal protection from the injury banage
brought about by incision and subsequent noxious surgical
events. This conclusion is supported by the high pain
scores observed immediately after surgery in the group that
received hi gh dose alfentanil periopcratively.
In conclusion, administration of high dose alfentanil
during abdominal hysterectomy led to reduced pain and
morphine consumption up to 6 h after surgery when com-
pared with a low dose alfentanil group and up to 12 h when
compared with a group that did not receive systemic
opioids during surgery. A subtle pre-emptive analgesic
effect was detected at 4 h after surgery in the low dose
group relative to untreated controls, suggesting that routine
doses of systemic opioids administered before and during
surgery do contribute to reduced post-operative pain hours
later. Overall, high dose patients appeared to be more com-
fortable 24h after surgery as evidenced by fewer patients
endorsing descriptors indicative of pain on the MPQ. The
incidence and intensity of pain 6 months after surgery did
not differ significantly among the three groups. The safety
of the high dose alfentanil regimen is confirmed by the
absence of adverse effects, and is predictable in this healthy
patient population, given the pharmacokinetic profile of
alfentanil. The requirement for propranolol in group I sup-
ports the role of moderate and high-dose alfentanil regi-
mens in achieving and maintaining intra-operative hemo-
dynamic stability.
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